首页|抗疟药在非洲使用情况的门诊处方分析

抗疟药在非洲使用情况的门诊处方分析

扫码查看
原文链接
  • 国家科技期刊平台
  • NETL
  • NSTL
  • 万方数据
  • 维普
目的:了解门诊疟疾患者用药基本情况,为合理用药提供参考.方法:对2010年8月—2011年3月非洲驻地门诊收治疟疾患者的处方进行统计分析.结果:非洲全年任何月份均有疟疾传播,抗疟药用药量雨季大于旱季；287张疟疾患者门诊处方中,用量排序前3位的抗疟药为双氢青蒿素哌喹片(113张,占39.37％)、蒿甲醚注射剂(65张,占22.65％)、注射用青蒿琥酯(46张,占16.03％).结论:青蒿素类药是治疗疟疾安全、有效的首选药物；赴非洲工作的医务人员应该充分了解各种抗疟药,依据其作用机制和不同特点,采用最佳治疗方案,以促进临床合理用药.
Use of Anti-malarial Drugs in Africa: Analysis of Outpatient Prescriptions
OBJECTIVE: To probe into the drug use in patients with malaria for clinical references of rational drug use. METHODS: The prescriptions of outpatients with malaria in local clinics in Africa between Aug. 2010 and Mar. 2011 were statistically analyzed. RESULTS: There was malaria transmission in any month throughout the whole year, and the consumption amount of anti-malarial drug in rainy season was more than that in dry season. Among the total 287 outpatients' prescriptions for malaria, dihydroartemisinin piperaquine phosphate tablets( DPPT) took the lead with 113(39. 37% ), followed by artemether injection with 65(22. 65% ) and artesunate for injection with 46( 16. 03% ). CONCLUSION: Arteannuin is safe and effective anti-malarial therapy of first choice. Medical staff working in Africa should get full understanding of various anti-malarial drugs and adopt optimal therapy based on action mechanism and characteristics so as to promote clinical rational drug use.

MalariaPrescriptionInvestigation and analysisArteannuin anti-malarial drugsRational drug use

安瑗、陈晓红、赵志刚、王慧媛

展开 >

北京积水潭医院药剂科,北京100035

首都医科大学附属北京天坛医院药剂科,北京100050

疟疾 处方 调查分析 青蒿素类抗疟药 合理用药

2011

中国医院用药评价与分析
中国医药生物技术协会，中国药房杂志社

中国医院用药评价与分析

影响因子：1.142
ISSN：1672-2124
年,卷(期)：2011.11(8)
  • 1
  • 5